mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients.
Nil AlbiolOlga AsoLucía Gómez-PérezMercè TriquellNerea RochElisabeth LázaroAlbert EsquirolIria GonzálezJoaquín López-ContrerasJorge SierraRodrigo MartinoGarcía-Cadenas IrenePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
Our study confirms that the mRNA-1273 SARS-CoV-2 vaccine is safe in recent HCT recipients and suggests that the perceived risk of COVID-19 decreases over time.